The EGF Receptor and HER2 Participate in TNF-α-Dependent MAPK Activation and IL-8 Secretion in Intestinal Epithelial Cells

TNF-α activates multiple mitogen-activated protein kinase (MAPK) cascades in intestinal epithelial cells (IECs) leading to the secretion of interleukin 8 (IL-8), a neutrophil chemoattractant and an angiogenic factor with tumor promoting properties. As the epidermal growth factor receptor (EGFR) is...

Full description

Saved in:
Bibliographic Details
Main Authors: Humberto B. Jijon, Andre Buret, Christina L. Hirota, Morley D. Hollenberg, Paul L. Beck
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2012/207398
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549139809828864
author Humberto B. Jijon
Andre Buret
Christina L. Hirota
Morley D. Hollenberg
Paul L. Beck
author_facet Humberto B. Jijon
Andre Buret
Christina L. Hirota
Morley D. Hollenberg
Paul L. Beck
author_sort Humberto B. Jijon
collection DOAJ
description TNF-α activates multiple mitogen-activated protein kinase (MAPK) cascades in intestinal epithelial cells (IECs) leading to the secretion of interleukin 8 (IL-8), a neutrophil chemoattractant and an angiogenic factor with tumor promoting properties. As the epidermal growth factor receptor (EGFR) is a known transducer of proliferative signals and a potent activator of MAPKs, we hypothesized that the EGFR participates in TNF-dependent MAPK activation and IL-8 secretion by intestinal epithelial cells (IECs). We show that the EGFR is tyrosine-phosphorylated following treatment of IECs (HT-29 and IEC-6) with TNF-α. This requires EGFR autophosphorylation as it was blocked by the EGFR kinase inhibitor AG1478. Autophosphorylation was also inhibited by both a Src-kinase inhibitor and the metalloproteinase inhibitor batimastat. TNF treatment of IECs resulted in the accumulation of soluble TGF-α; treatment of IECs with batimastat suppressed TGF-α release and immunoneutralization of TGF-α resulted in decreased EGFR and ERK phosphorylations. TNF-α treatment of IECs resulted in an association between EGFR and HER2 and inhibition of HER2 using a specific inhibitor AG879 in combination with AG1478-suppressed TNF-α-dependent ERK phosphorylation and IL-8 release. Downregulation of HER2 via siRNA resulted in a significant decrease in ERK phosphorylation and a 50% reduction in IL-8 secretion.
format Article
id doaj-art-ff1407a1833f4388a44786d93b33a9ef
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-ff1407a1833f4388a44786d93b33a9ef2025-02-03T06:12:10ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/207398207398The EGF Receptor and HER2 Participate in TNF-α-Dependent MAPK Activation and IL-8 Secretion in Intestinal Epithelial CellsHumberto B. Jijon0Andre Buret1Christina L. Hirota2Morley D. Hollenberg3Paul L. Beck4Gastrointestinal Research Group, Health Sciences Centre, University of Calgary, Calgary, AB, T2N 1N4, CanadaGastrointestinal Research Group, Health Sciences Centre, University of Calgary, Calgary, AB, T2N 1N4, CanadaGastrointestinal Research Group, Health Sciences Centre, University of Calgary, Calgary, AB, T2N 1N4, CanadaGastrointestinal Research Group, Health Sciences Centre, University of Calgary, Calgary, AB, T2N 1N4, CanadaGastrointestinal Research Group, Health Sciences Centre, University of Calgary, Calgary, AB, T2N 1N4, CanadaTNF-α activates multiple mitogen-activated protein kinase (MAPK) cascades in intestinal epithelial cells (IECs) leading to the secretion of interleukin 8 (IL-8), a neutrophil chemoattractant and an angiogenic factor with tumor promoting properties. As the epidermal growth factor receptor (EGFR) is a known transducer of proliferative signals and a potent activator of MAPKs, we hypothesized that the EGFR participates in TNF-dependent MAPK activation and IL-8 secretion by intestinal epithelial cells (IECs). We show that the EGFR is tyrosine-phosphorylated following treatment of IECs (HT-29 and IEC-6) with TNF-α. This requires EGFR autophosphorylation as it was blocked by the EGFR kinase inhibitor AG1478. Autophosphorylation was also inhibited by both a Src-kinase inhibitor and the metalloproteinase inhibitor batimastat. TNF treatment of IECs resulted in the accumulation of soluble TGF-α; treatment of IECs with batimastat suppressed TGF-α release and immunoneutralization of TGF-α resulted in decreased EGFR and ERK phosphorylations. TNF-α treatment of IECs resulted in an association between EGFR and HER2 and inhibition of HER2 using a specific inhibitor AG879 in combination with AG1478-suppressed TNF-α-dependent ERK phosphorylation and IL-8 release. Downregulation of HER2 via siRNA resulted in a significant decrease in ERK phosphorylation and a 50% reduction in IL-8 secretion.http://dx.doi.org/10.1155/2012/207398
spellingShingle Humberto B. Jijon
Andre Buret
Christina L. Hirota
Morley D. Hollenberg
Paul L. Beck
The EGF Receptor and HER2 Participate in TNF-α-Dependent MAPK Activation and IL-8 Secretion in Intestinal Epithelial Cells
Mediators of Inflammation
title The EGF Receptor and HER2 Participate in TNF-α-Dependent MAPK Activation and IL-8 Secretion in Intestinal Epithelial Cells
title_full The EGF Receptor and HER2 Participate in TNF-α-Dependent MAPK Activation and IL-8 Secretion in Intestinal Epithelial Cells
title_fullStr The EGF Receptor and HER2 Participate in TNF-α-Dependent MAPK Activation and IL-8 Secretion in Intestinal Epithelial Cells
title_full_unstemmed The EGF Receptor and HER2 Participate in TNF-α-Dependent MAPK Activation and IL-8 Secretion in Intestinal Epithelial Cells
title_short The EGF Receptor and HER2 Participate in TNF-α-Dependent MAPK Activation and IL-8 Secretion in Intestinal Epithelial Cells
title_sort egf receptor and her2 participate in tnf α dependent mapk activation and il 8 secretion in intestinal epithelial cells
url http://dx.doi.org/10.1155/2012/207398
work_keys_str_mv AT humbertobjijon theegfreceptorandher2participateintnfadependentmapkactivationandil8secretioninintestinalepithelialcells
AT andreburet theegfreceptorandher2participateintnfadependentmapkactivationandil8secretioninintestinalepithelialcells
AT christinalhirota theegfreceptorandher2participateintnfadependentmapkactivationandil8secretioninintestinalepithelialcells
AT morleydhollenberg theegfreceptorandher2participateintnfadependentmapkactivationandil8secretioninintestinalepithelialcells
AT paullbeck theegfreceptorandher2participateintnfadependentmapkactivationandil8secretioninintestinalepithelialcells
AT humbertobjijon egfreceptorandher2participateintnfadependentmapkactivationandil8secretioninintestinalepithelialcells
AT andreburet egfreceptorandher2participateintnfadependentmapkactivationandil8secretioninintestinalepithelialcells
AT christinalhirota egfreceptorandher2participateintnfadependentmapkactivationandil8secretioninintestinalepithelialcells
AT morleydhollenberg egfreceptorandher2participateintnfadependentmapkactivationandil8secretioninintestinalepithelialcells
AT paullbeck egfreceptorandher2participateintnfadependentmapkactivationandil8secretioninintestinalepithelialcells